Typically, patients of our weight loss program in West Sacramento, California who start FDA-approved GLP-1 medications like Ozempic and Wegovy lose an average 15% of their weight when combined with diet and exercise
In combination with Tums, the medication may get into the bloodstream in increased proportions than are desired leading to enhanced actions like increased focus and energy
DiMarchi created new dual agonists, targeting GLP-1 and GIP receptors, and in mice, they found these compounds to be more effective at weight loss than existing drugs that target just GLP-1
Some peptides may not be FDA-approved for all uses, and using them for unapproved purposes may carry regulatory or legal risk
Wegovy (semaglutide) prescribing information
Vinpocetine is as potent as phenytoin to block voltage-gated Na+ channels in rat cortical neurons